THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN DRUG-REFRACTORY VENTRICULAR TACHYARRHYTHMIAS

被引：118
|
作者：
FOGOROS, RN [1 ]
FIEDLER, SB [1 ]
ELSON, JJ [1 ]
机构：
[1] UNIV PITTSBURGH, DIV CARDIOL, PITTSBURGH, PA 15260 USA
来源：
ANNALS OF INTERNAL MEDICINE | 1987年 / 107卷 / 05期
关键词：
D O I：
10.7326/0003-4819-107-5-635
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 641
页数：7
相关论文
共 50 条
  • [41] Drug-implantable cardioverter-defibrillator interactions
    Beadle, Roger
    Williams, Lynne
    Lim, Hoong Sern
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (09) : 1267 - 1273
  • [42] Therapeutic options for malignant ventricular tachyarrhythmias: Is the implantable cardioverter-defibrillator a primary alternative or merely complementary?
    Capucci, A
    Aschieri, D
    Villani, GQ
    Rosi, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (5A): : 89 - 91
  • [43] CIRCADIAN VARIATION OF SUSTAINED VENTRICULAR TACHYARRHYTHMIAS TERMINATED BY APPROPRIATE SHOCKS IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    BEHRENS, S
    GALECKA, M
    BRUGGEMANN, T
    EHLERS, C
    WILLICH, SN
    ZISS, W
    DISSMANN, R
    ANDRESEN, D
    AMERICAN HEART JOURNAL, 1995, 130 (01) : 79 - 84
  • [44] Ventricular Tachyarrhythmias in Patients Receiving an Implantable Cardioverter-Defibrillator for Primary versus Secondary Prophylaxis Indications
    Manuchehry, Amin
    Agusala, Kartik
    Montevecchi, Mauro
    Kadish, Alan
    Passman, Rod
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (05): : 571 - 576
  • [45] Oral mexiletine for ventricular tachyarrhythmias treatment in implantable cardioverter-defibrillator patients: a systematic review of the literature
    Ali, Hussam
    Cristiano, Ernesto
    Lupo, Pierpaolo
    Foresti, Sara
    De Ambroggi, Guido
    De Lucia, Carmine
    Turturiello, Dario
    Paganini, Edoardo M.
    Bessi, Riccardo
    Farghaly, Ahmad A.
    Nicoli, Leoluca
    Cappato, Riccardo
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (06) : 622 - 630
  • [46] Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks
    Sobiech, Marcin
    Lewandowski, Michal
    Zajac, Dariusz
    Maciag, Aleksander
    Syska, Pawel
    Atenska-Pawlowska, Joanna
    Kowalik, Ilona
    Sterlinski, Maciej
    Szwed, Hanna
    Pytkowski, Mariusz
    KARDIOLOGIA POLSKA, 2017, 75 (10) : 1027 - 1032
  • [47] Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator
    Garcia-Moran, E
    Mont, L
    Cuesta, A
    Matas, M
    Brugada, J
    EUROPEAN HEART JOURNAL, 2002, 23 (11) : 901 - 907
  • [48] EFFECT OF PROPHYLACTIC ANTIARRHYTHMIC THERAPY ON TIME TO IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DISCHARGE IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS
    ANDERSON, JL
    KARAGOUNIS, LA
    ROSKELLEY, M
    OSBORN, JS
    HANDRAHAN, D
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (09): : 683 - 687
  • [49] Molecular mechanisms of heart failure progression associated with implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias
    Tsuji, Yukiomi
    Ishikawa, Taisuke
    Makita, Naomasa
    JOURNAL OF ARRHYTHMIA, 2014, 30 (04) : 235 - 241
  • [50] Individualization of follow-up in implantable cardioverter-defibrillator patients with the help of automatic remote implantable cardioverter-defibrillator monitoring
    Neuser, H
    Schumacher, B
    Kottkamp, H
    Schmidinger, H
    Schuchert, A
    Brugada, P
    EUROPEAN HEART JOURNAL, 2004, 25 : 166 - 166
12345